Although emerging evidence has revealed a key role for SMAD4 deficiency in driving PDAC [17–20], the molecular mechanisms underlying the contribution of SMAD4 loss to tumor malignancy in PDAC is less well defined. Here, SMAD4 is linked to neoplasm.